List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Meningococcal Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polysaccharide
1.2.3 Conjugate
1.2.4 Combination
1.3 Market by Application
1.3.1 Global Meningococcal Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global Meningococcal Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global Meningococcal Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Meningococcal Vaccination Sales by Region
2.4.1 Global Meningococcal Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales Meningococcal Vaccination by Region (2023-2028)
2.5 Global Meningococcal Vaccination Revenue by Region
2.5.1 Global Meningococcal Vaccination Revenue by Region (2017-2022)
2.5.2 Global Meningococcal Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Meningococcal Vaccination Sales by Manufacturers
3.1.1 Global Top Meningococcal Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global Meningococcal Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningococcal Vaccination in 2021
3.2 Global Meningococcal Vaccination Revenue by Manufacturers
3.2.1 Global Meningococcal Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global Meningococcal Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccination Revenue in 2021
3.3 Global Meningococcal Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Meningococcal Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meningococcal Vaccination Sales by Type
4.1.1 Global Meningococcal Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global Meningococcal Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global Meningococcal Vaccination Sales Market Share by Type (2017-2028)
4.2 Global Meningococcal Vaccination Revenue by Type
4.2.1 Global Meningococcal Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global Meningococcal Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global Meningococcal Vaccination Price by Type
4.3.1 Global Meningococcal Vaccination Price by Type (2017-2022)
4.3.2 Global Meningococcal Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Meningococcal Vaccination Sales by Application
5.1.1 Global Meningococcal Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global Meningococcal Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global Meningococcal Vaccination Sales Market Share by Application (2017-2028)
5.2 Global Meningococcal Vaccination Revenue by Application
5.2.1 Global Meningococcal Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global Meningococcal Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global Meningococcal Vaccination Price by Application
5.3.1 Global Meningococcal Vaccination Price by Application (2017-2022)
5.3.2 Global Meningococcal Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America Meningococcal Vaccination Market Size by Type
6.1.1 North America Meningococcal Vaccination Sales by Type (2017-2028)
6.1.2 North America Meningococcal Vaccination Revenue by Type (2017-2028)
6.2 North America Meningococcal Vaccination Market Size by Application
6.2.1 North America Meningococcal Vaccination Sales by Application (2017-2028)
6.2.2 North America Meningococcal Vaccination Revenue by Application (2017-2028)
6.3 North America Meningococcal Vaccination Market Size by Country
6.3.1 North America Meningococcal Vaccination Sales by Country (2017-2028)
6.3.2 North America Meningococcal Vaccination Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Meningococcal Vaccination Market Size by Type
7.1.1 Europe Meningococcal Vaccination Sales by Type (2017-2028)
7.1.2 Europe Meningococcal Vaccination Revenue by Type (2017-2028)
7.2 Europe Meningococcal Vaccination Market Size by Application
7.2.1 Europe Meningococcal Vaccination Sales by Application (2017-2028)
7.2.2 Europe Meningococcal Vaccination Revenue by Application (2017-2028)
7.3 Europe Meningococcal Vaccination Market Size by Country
7.3.1 Europe Meningococcal Vaccination Sales by Country (2017-2028)
7.3.2 Europe Meningococcal Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Meningococcal Vaccination Market Size by Type
8.1.1 Asia Pacific Meningococcal Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific Meningococcal Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific Meningococcal Vaccination Market Size by Application
8.2.1 Asia Pacific Meningococcal Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific Meningococcal Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific Meningococcal Vaccination Market Size by Region
8.3.1 Asia Pacific Meningococcal Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific Meningococcal Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Meningococcal Vaccination Market Size by Type
9.1.1 Latin America Meningococcal Vaccination Sales by Type (2017-2028)
9.1.2 Latin America Meningococcal Vaccination Revenue by Type (2017-2028)
9.2 Latin America Meningococcal Vaccination Market Size by Application
9.2.1 Latin America Meningococcal Vaccination Sales by Application (2017-2028)
9.2.2 Latin America Meningococcal Vaccination Revenue by Application (2017-2028)
9.3 Latin America Meningococcal Vaccination Market Size by Country
9.3.1 Latin America Meningococcal Vaccination Sales by Country (2017-2028)
9.3.2 Latin America Meningococcal Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Vaccination Market Size by Type
10.1.1 Middle East and Africa Meningococcal Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa Meningococcal Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa Meningococcal Vaccination Market Size by Application
10.2.1 Middle East and Africa Meningococcal Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa Meningococcal Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa Meningococcal Vaccination Market Size by Country
10.3.1 Middle East and Africa Meningococcal Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa Meningococcal Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 JN-International Medical
11.2.1 JN-International Medical Corporation Information
11.2.2 JN-International Medical Overview
11.2.3 JN-International Medical Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 JN-International Medical Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 JN-International Medical Recent Developments
11.3 Novartis International
11.3.1 Novartis International Corporation Information
11.3.2 Novartis International Overview
11.3.3 Novartis International Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis International Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis International Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Baxter International
11.6.1 Baxter International Corporation Information
11.6.2 Baxter International Overview
11.6.3 Baxter International Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter International Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter International Recent Developments
11.7 Biomed
11.7.1 Biomed Corporation Information
11.7.2 Biomed Overview
11.7.3 Biomed Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biomed Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biomed Recent Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Corporation Information
11.8.2 Serum Institute of India Overview
11.8.3 Serum Institute of India Meningococcal Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Serum Institute of India Meningococcal Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Serum Institute of India Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meningococcal Vaccination Industry Chain Analysis
12.2 Meningococcal Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningococcal Vaccination Production Mode & Process
12.4 Meningococcal Vaccination Sales and Marketing
12.4.1 Meningococcal Vaccination Sales Channels
12.4.2 Meningococcal Vaccination Distributors
12.5 Meningococcal Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Meningococcal Vaccination Industry Trends
13.2 Meningococcal Vaccination Market Drivers
13.3 Meningococcal Vaccination Market Challenges
13.4 Meningococcal Vaccination Market Restraints
14 Key Findings in The Global Meningococcal Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
